Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Esophagus (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 3.1 (3.0, 3.1) N/A 12,239 67.4
District of Columbia 6 2.0 (1.6, 2.6) 50 (38, 50) 14 57.9
New Mexico 3 2.0 (1.8, 2.3) 49 (44, 50) 57 55.6
Utah 3 2.1 (1.9, 2.4) 48 (43, 50) 60 70.8
Texas 3 2.3 (2.2, 2.3) 47 (44, 50) 664 58.2
California 3 2.3 (2.3, 2.4) 46 (43, 48) 1,039 67.5
Arizona 6 2.3 (2.2, 2.5) 45 (42, 49) 211 57.8
Wyoming 6 2.4 (1.9, 3.0) 44 (25, 50) 18 62.9
Hawaii 3 2.6 (2.3, 3.0) 43 (28, 49) 50 72.0
Arkansas 6 2.7 (2.5, 2.9) 42 (29, 46) 106 61.1
Alabama 6 2.7 (2.5, 2.9) 41 (30, 44) 173 60.4
Florida 6 2.8 (2.7, 2.9) 40 (34, 44) 848 59.8
Colorado 6 2.8 (2.6, 3.0) 39 (29, 44) 176 68.9
Virginia 6 2.8 (2.7, 3.0) 38 (30, 44) 289 68.6
New Jersey 3 2.8 (2.7, 3.0) 37 (29, 43) 323 66.2
Oklahoma 6 2.9 (2.6, 3.1) 36 (25, 44) 137 62.0
Georgia 3 2.9 (2.8, 3.0) 35 (27, 42) 345 67.4
Maryland 6 2.9 (2.7, 3.1) 34 (26, 43) 213 67.9
Louisiana 3 2.9 (2.7, 3.1) 33 (25, 43) 167 66.8
North Carolina 6 3.0 (2.8, 3.1) 32 (26, 40) 382 71.5
South Carolina 6 3.0 (2.9, 3.2) 31 (22, 40) 205 68.5
Tennessee 6 3.1 (2.9, 3.2) 30 (23, 39) 262 63.6
New York 3 3.1 (3.0, 3.2) 29 (25, 35) 764 69.4
Mississippi 6 3.1 (2.8, 3.4) 28 (18, 42) 115 65.6
Washington 5 3.3 (3.1, 3.4) 27 (17, 32) 291 67.1
Delaware 6 3.3 (2.8, 3.8) 26 (7, 42) 42 68.5
Illinois 3 3.3 (3.2, 3.4) 25 (17, 29) 517 69.8
Nebraska 6 3.3 (3.0, 3.7) 24 (9, 37) 79 69.4
Kansas 6 3.3 (3.1, 3.6) 23 (11, 34) 117 70.0
Idaho 3 3.4 (3.0, 3.7) 22 (8, 37) 69 69.5
Connecticut 3 3.4 (3.2, 3.7) 21 (10, 30) 164 73.0
Minnesota 6 3.5 (3.3, 3.7) 20 (10, 27) 243 71.6
Montana 6 3.5 (3.1, 4.0) 19 (3, 38) 50 71.9
Rhode Island 6 3.5 (3.1, 4.0) 18 (4, 35) 50 70.4
Oregon 6 3.5 (3.3, 3.8) 17 (8, 27) 192 72.2
Missouri 6 3.6 (3.4, 3.8) 16 (9, 25) 280 69.6
Michigan 6 3.6 (3.5, 3.8) 15 (9, 22) 476 67.4
Kentucky 3 3.6 (3.4, 3.9) 14 (6, 25) 206 67.8
Vermont 6 3.7 (3.2, 4.4) 13 (2, 36) 34 68.0
North Dakota 6 3.7 (3.2, 4.4) 12 (2, 35) 32 75.0
Massachusetts 3 3.8 (3.6, 4.0) 11 (5, 20) 331 71.1
South Dakota 6 3.8 (3.3, 4.4) 10 (2, 32) 42 74.6
Ohio 6 3.9 (3.7, 4.0) 9 (5, 16) 587 68.8
Pennsylvania 6 3.9 (3.8, 4.0) 8 (4, 14) 684 72.6
Alaska 6 3.9 (3.2, 4.6) 7 (1, 36) 29 73.9
Indiana 6 4.1 (3.9, 4.3) 6 (3, 13) 332 74.4
Wisconsin 6 4.1 (3.9, 4.3) 5 (2, 13) 307 76.5
Iowa 3 4.2 (3.9, 4.5) 4 (2, 12) 170 73.0
West Virginia 6 4.3 (3.9, 4.7) 3 (1, 12) 113 73.7
New Hampshire 6 4.6 (4.2, 5.1) 2 (1, 7) 89 70.4
Maine 6 5.1 (4.7, 5.6) 1 (1, 3) 103 75.1
Nevada 6
data not available
N/A
data not available
data not available
Puerto Rico 6 1.1 (0.9, 1.2) N/A 46 37.6
Notes:
Created by statecancerprofiles.cancer.gov on 12/08/2022 9:43 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada, Puerto Rico

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top